Home Cart Sign in  
Chemical Structure| 25368-11-0 Chemical Structure| 25368-11-0

Structure of Asperulosidic Acid
CAS No.: 25368-11-0

Chemical Structure| 25368-11-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Asperulosidic acid is a cycloether terpenoid extracted from the plant Euphorbia hirta, showing antitumor, antioxidant, and anti-inflammatory effects. It reduces inflammatory cytokine release (TNF-α, IL-6) by inhibiting the NF-κB and MAPK signaling pathways, indicating potential anti-inflammatory applications.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Asperulosidic Acid

CAS No. :25368-11-0
Formula : C18H24O12
M.W : 432.38
SMILES Code : CC(OCC1=C[C@@H]([C@@]2([H])[C@]1([H])[C@@H](OC=C2C(O)=O)OC3C(O)C(O)C(O)C(CO)O3)O)=O
MDL No. :MFCD21333373
InChI Key :DGDWCRWJRNMRKX-DILZHRMZSA-N
Pubchem ID :11968867

Safety of Asperulosidic Acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Asperulosidic Acid

MAPK
pyroptosis

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.56mL

2.31mL

1.16mL

23.13mL

4.63mL

2.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories